Stocks to watch
Upgrades, downgrades, or major signals – these stocks are making waves.
The stock screener that catches what looks good but isn't.
Compare Health, Risk, Performance, and Trend on every stock, side by side.
Overall stock screener, find the best stocks at a glance. Rankings combine Stoxcraft Rating, Health, Performance, Risk, Trend and BuyMeter, so you see what matters first. Filter by sector, market cap or dividend, and check the Earnings Streak to spot stocks that consistently beat expectations.
| Symbol | Name | Rating | Price | Today | Health | Performance | Risk | Trend | BuyMeter | ESG Score | Earning Streak | Market Cap | Volume | P/E | Dividend | Sector | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MOH
|
Molina Healthcare, Inc. | 196.45 USD | +2.38 % | 6.7 | Sell | 62.38 | 10.21B | 1.21M | 19 | - | Healthcare | Medical - Healthcare Plans | |||||
|
WBA
|
Walgreens Boots Alliance, Inc. | 11.98 USD | +0.50 % | 1.4 | Hold | 55.16 | 10.37B | 16.94M | -1 | - | Healthcare | Medical - Pharmaceuticals | |||||
|
OPCH
|
Option Care Health, Inc. | 23.79 USD | +0.68 % | 6.7 | Buy | 69.20 | 3.62B | 3.22M | 25 | - | Healthcare | Medical - Care Facilities | |||||
|
ALHC
|
Alignment Healthcare, Inc. | 14.37 USD | +7.40 % | 9.0 | Sell | 67.41 | 3.07B | 6.08M | -5338 | - | Healthcare | Medical - Healthcare Plans | |||||
|
PRVA
|
Privia Health Group, Inc. | 22.45 USD | +2.05 % | 5.2 | Hold | 67.85 | 2.98B | 1.13M | 125 | - | Healthcare | Medical - Healthcare Information Services | |||||
|
HCM
|
HUTCHMED (China) Limited | 12.51 USD | +5.75 % | 5.5 | Hold | 63.39 | 1.94B | 51,166 | 5 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
ELAN
|
Elanco Animal Health Incorporated | 22.12 USD | -8.60 % | 6.6 | Strong Sell | 68.23 | 13.18B | 5.90M | -48 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
IONS
|
Ionis Pharmaceuticals, Inc. | 56.56 USD | +3.80 % | 7.2 | Strong Sell | 49.83 | 8.60B | 2.76M | -33 | - | Healthcare | Biotechnology | |||||
|
OGN
|
Organon & Co. | 13.60 USD | +0.37 % | 6.3 | Buy | 73.34 | 3.56B | 3.20M | 10 | 0.59 % | Healthcare | Drug Manufacturers - General | |||||
|
STVN
|
Stevanato Group S.p.A. | 20.27 USD | -0.10 % | 6.4 | Buy | 71.84 | 5.42B | 362,933 | 35 | - | Healthcare | Medical - Instruments & Supplies | |||||
|
SWTX
|
SpringWorks Therapeutics, Inc. | 46.99 USD | +0.02 % | 6.6 | Sell | 56.85 | 3.54B | 5.85M | -10 | - | Healthcare | Biotechnology | |||||
|
TFX
|
Teleflex Incorporated | 134.98 USD | -2.82 % | 3.8 | Hold | 54.01 | 6.05B | 563,170 | -6 | 1.02 % | Healthcare | Medical - Instruments & Supplies | |||||
|
WRBY
|
Warby Parker Inc. | 26.46 USD | -1.85 % | 8.1 | Strong Sell | 82.74 | 3.28B | 3.28M | 1626 | - | Consumer Cyclical | Specialty Retail | |||||
|
BCRX
|
BioCryst Pharmaceuticals, Inc. | 9.38 USD | +0.86 % | 4.8 | Sell | 58.32 | 2.28B | 4.95M | 6 | - | Healthcare | Biotechnology | |||||
|
ATRC
|
AtriCure, Inc. | 41.39 USD | +4.81 % | 5.4 | Buy | 79.72 | 1.92B | 959,491 | -165 | - | Healthcare | Medical - Instruments & Supplies | |||||
|
PCRX
|
Pacira BioSciences, Inc. | 25.02 USD | -2.19 % | 3.7 | Buy | 60.95 | 1.04B | 504,009 | 162 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
AMPH
|
Amphastar Pharmaceuticals, Inc. | 20.78 USD | +4.90 % | 7.2 | Buy | 67.49 | 879.21M | 612,729 | 13 | - | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
ARDT
|
Ardent Health Inc. | 11.55 USD | -0.35 % | 5.2 | Hold | 54.67 | 1.53B | 557,675 | 9 | - | Healthcare | Medical - Care Facilities | |||||
|
CLOV
|
Clover Health Investments, Corp. | 4.76 USD | +2.15 % | 8.9 | Sell | 72.18 | 2.16B | 7.38M | -14 | - | Healthcare | Medical - Healthcare Plans | |||||
|
GDS
|
GDS Holdings Limited | 31.98 USD | +0.44 % | 7.7 | Hold | 66.53 | 6.38B | 2.41M | 51 | - | Technology | Information Technology Services | |||||
|
GLPG
|
Galapagos N.V. | 27.98 USD | +1.71 % | 4.3 | Buy | 75.61 | 1.84B | 187,564 | 6 | - | Healthcare | Biotechnology | |||||
|
OMCL
|
Omnicell, Inc. | 36.81 USD | +1.80 % | 6.3 | Hold | 75.01 | 1.61B | 692,441 | 1016 | - | Healthcare | Medical - Equipment & Services | |||||
|
USPH
|
U.S. Physical Therapy, Inc. | 80.05 USD | +4.70 % | 6.7 | Buy | 80.08 | 1.20B | 243,012 | 55 | 2.94 % | Healthcare | Medical - Care Facilities | |||||
|
EMBC
|
Embecta Corp. | 4.42 USD | +26.29 % | 8.9 | Hold | 70.48 | 215.95M | 2.57M | 9 | 13.81 % | Healthcare | Drug Manufacturers - Specialty & Generic | |||||
|
DAWN
|
Day One Biopharmaceuticals, Inc. | 21.53 USD | 0.00 % | 9.9 | Sell | 62.16 | 2.22B | 4.01M | -9 | - | Healthcare | Biotechnology | |||||
|
MDXG
|
MiMedx Group, Inc. | 4.34 USD | +3.83 % | 7.8 | Hold | 70.11 | 601.99M | 1.44M | 21 | - | Healthcare | Biotechnology | |||||
|
SRDX
|
Surmodics, Inc. | 42.98 USD | +0.35 % | 4.3 | Sell | 67.61 | 614.51M | 435,959 | -47 | - | Healthcare | Medical - Devices | |||||
|
TBRG
|
TruBridge, Inc. | 26.24 USD | 0.00 % | 5.9 | Buy | 66.55 | 393.58M | 326,407 | 76 | - | Healthcare | Medical - Healthcare Information Services | |||||
|
NRC
|
NRC Health | 20.34 USD | +4.47 % | 6.2 | Buy | 84.74 | 439.69M | 125,364 | 36 | 3.28 % | Healthcare | Medical - Healthcare Information Services | |||||
|
NCDL
|
Nuveen Churchill Direct Lending Corp. | 12.82 USD | +2.31 % | 3.7 | Buy | 61.93 | 598.57M | 207,629 | 10 | 14.24 % | Financial Services | Asset Management |
The stock screener that compares every stock to the right benchmark
Stoxcraft is a free stock screener, and it doesn't just dump numbers on you. On the Health tab, every fundamental metric is color coded against its sector average, so you see instantly whether a number is actually good, or just average dressed up as good. The Risk tab flips the comparison to the overall market instead of a sector. A calm balance sheet is a calm balance sheet, whether you're in Tech or Utilities.
No finance degree required. Dividend hunters can turn on Dividends Only and use this as a dedicated dividend stock screener, built to separate real payout safety from a headline yield. Day traders get the Trend tab instead, RSI and volume doing the real talking before a move even shows up in the price. And for anyone screening with a longer horizon, this doubles as a growth stock screener too: Revenue Growth 5Y sits right next to Income Growth 5Y, so you can tell a real compounder from one good quarter. Pick a tab, and know within seconds whether a stock deserves a second look.